Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
R1 RCM Inc.

Start price
Target price
Perf. (%)
€14.89
17.10.20
-
04.11.21
50.44%
05.11.21

melinda 
17.10.20 50%
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€12.90
17.10.20
-
04.11.21
-29.07%
24.03.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Risky balance sheet
FXX 
17.10.20 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.60
17.10.20
-
01.11.20
-6.54%
01.11.20

Ellritze 
17.10.20 50%
buy
Heat Biologics Inc.

Start price
Target price
Perf. (%)
€7.57
17.10.20
-
04.11.21
-36.70%
05.11.21

Rick_NRW 
17.10.20 50%
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€93.61
17.10.20
-
04.11.21
19.59%
05.11.21

Rick_NRW 
17.10.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.50
17.10.20
€33.21
04.11.21
34.92%
18.08.21

KingKong 
17.10.20 50%
buy
Myovant Sciences Ltd

Start price
Target price
Perf. (%)
€13.80
17.10.20
-
04.11.21
19.57%
03.04.21

KongVestor 
17.10.20 50%
buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€120.76
17.10.20
-
04.11.21
-47.70%
03.04.21

KongVestor 
17.10.20 50%
sell
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€24.58
17.10.20
-
04.11.21
47.97%
03.04.21

KongVestor 
17.10.20 50%
buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€14.20
16.10.20
€18.00
04.11.21
143.66%
05.11.21

melinda 
16.10.20 50%
sell
Rewalk Robotics Ltd.

Start price
Target price
Perf. (%)
€1.46
16.10.20
€1.00
30.10.20
-34.07%
30.10.20

blaugold 
16.10.20 50%
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€125.04
16.10.20
€120.00
04.11.21
4.56%
09.12.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
16.10.20 50%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€51.93
15.10.20
-
04.11.21
-1.54%
18.12.20

NightmareKing 
15.10.20 50%
buy
Medigene AG

Start price
Target price
Perf. (%)
€3.51
15.10.20
€5.00
19.10.20
0.28%
19.10.20

Could be worthwhile Investment >10% per year
DomRuinart 
15.10.20 50%
sell
Evotec SE

Start price
Target price
Perf. (%)
€22.76
15.10.20
-
04.11.21
16.65%
15.12.20

NightTrain 
15.10.20 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€4.10
15.10.20
€5.00
04.11.21
24.39%
18.11.20

blaugold 
15.10.20 50%
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€30.39
15.10.20
€31.00
18.10.20
3.52%
18.10.20

Could be very worthwhile Investment >20% year
Vassago1 
15.10.20 50%
buy
Paratek Pharma

Start price
Target price
Perf. (%)
€4.28
15.10.20
-
04.11.21
31.34%
24.01.21

NightmareKing 
15.10.20 50%
buy
Mereo BioPharma Group PLC

Start price
Target price
Perf. (%)
€0.34
14.10.20
€0.50
04.11.21
-22.35%
05.11.21

melinda 
14.10.20 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€4.66
14.10.20
-
04.11.21
118.03%
17.06.21

klostergang 
14.10.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.22
14.10.20
€47.00
04.11.21
8.47%
11.11.20

Undervalued
Risky Investment
phonebroker 
14.10.20 50%
buy
OncoCyte Corp

Start price
Target price
Perf. (%)
€1.78
14.10.20
€2.00
19.10.20
-28.09%
19.10.20

thomasw 
14.10.20 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€4.20
14.10.20
€8.00
04.11.21
181.22%
05.11.21

melinda 
14.10.20 50%
sell
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€126.00
14.10.20
€120.00
16.10.20
-0.76%
16.10.20

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Traumtanz 
14.10.20 50%
sell
Editas Medicine Inc

Start price
Target price
Perf. (%)
€27.82
13.10.20
€24.30
04.11.21
-6.72%
04.11.20

geldnutzer 
13.10.20 50%